Paper Details

  1. Home
  2. Paper Details

[Addition of bismuth subsalicylate to triple eradication therapy for Helicobacter pylori infection: efficiency and adverse events].

Author: Díaz FerrerJavier, Hinostroza MoralesDennis

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This study found that the addition of bismuth subsalicylate to triple eradication therapy for Helicobacter pylori infection was effective in 89.7% of patients, whereas 80% of patients receiving the standard triple therapy achieved eradication. The most common side effects were diarrhea, dark feces, and abdominal pain.
Paper Details　
Original Abstract of the Article :
OBJECTIVES: To establish the efficiency and adverse effects of the addition of bismuth subsalicylate to triple eradication therapy for Helicobacter pylori infection. MATERIAL AND METHODS: Double blind controlled experimental trial. The study population consisted of 54 patients with Helicobacter pyl...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/25594755

データ提供：米国国立医学図書館（NLM）

Bismuth Subsalicylate: A Potential Boost for Helicobacter pylori Eradication

This research delves into the world of Helicobacter pylori infection, a condition that can be as complex and elusive as a mirage in the desert. The researchers explored the effectiveness of adding bismuth subsalicylate to triple eradication therapy for H. pylori infection. They designed a double-blind controlled trial to compare the effectiveness of this combined therapy with traditional triple therapy alone.

Bismuth Subsalicylate: A Potential Advantage in H. pylori Eradication

This study suggests that adding bismuth subsalicylate to triple eradication therapy may be an effective approach to eliminating Helicobacter pylori infection. The results showed a significantly higher eradication rate in the group that received the combination therapy compared to the group that received only triple therapy. This finding could be valuable for patients who struggle to eradicate H. pylori with traditional therapy.

Helicobacter pylori: A Desert Journey to Healing

Helicobacter pylori infection can be a challenging condition to manage. This study provides a glimpse into a potential approach to enhancing eradication rates, offering hope to patients seeking relief from this persistent infection. The researchers noted that bismuth subsalicylate was well-tolerated and associated with fewer adverse events compared to placebo.

Dr.Camel's Conclusion

This study provides valuable insights into the potential benefits of adding bismuth subsalicylate to triple eradication therapy for Helicobacter pylori infection. The research suggests that this combination therapy may be more effective in eradicating H. pylori compared to traditional triple therapy alone. While further research is needed, this study offers a promising avenue for improving the treatment of this persistent infection.

Date :
  1. Date Completed 2016-10-28
  2. Date Revised 2016-12-30
Further Info :

Pubmed ID

25594755

DOI: Digital Object Identifier

05

SNS
PICO Info
in preparation
Languages

Spanish

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.